A severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine

dc.contributor.authorYilmaz, S
dc.contributor.authorDursum, M
dc.contributor.authorCanoruc, F
dc.contributor.authorBayan, K
dc.contributor.authorKarabulut, A
dc.contributor.authorAkay, H
dc.date.accessioned2024-04-24T17:33:12Z
dc.date.available2024-04-24T17:33:12Z
dc.date.issued2005
dc.departmentDicle Üniversitesien_US
dc.description.abstractThe hepatopulmonary syndrome has been defined as chronic liver disease accompanied by abnormal pulmonary gas exchange, which might result in arterial deoxygenation, and widespread intrapulmonary vasodilation. Although it has been pointed out that hepatopulmonary syndrome occurs in liver cirrhosis, there are a few studies in the literature reporting noncirrhotic portal hypertension as a cause of hepatopulmonary syndrome. Currently, liver transplantation is the only effective therapy for such patients. On the other hand, there is also a proposal about considering paroxetine, a potent nitric oxide synthase inhibitor, for use in the hepatopulmonary syndrome. We present a patient with severe (type II) hepatopulmonary syndrome caused by idiopathic portal hypertension and discuss the consequences of paroxetine therapy.en_US
dc.identifier.endpage452en_US
dc.identifier.issn0300-2977
dc.identifier.issn1872-9061
dc.identifier.issue11en_US
dc.identifier.pmid16397315
dc.identifier.scopus2-s2.0-29644435761
dc.identifier.scopusqualityQ3
dc.identifier.startpage448en_US
dc.identifier.urihttps://hdl.handle.net/11468/20522
dc.identifier.volume63en_US
dc.identifier.wosWOS:000234738100007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherVan Zuiden Communicationsen_US
dc.relation.ispartofNetherlands Journal of Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatopulmonary Syndromeen_US
dc.subjectParoxetineen_US
dc.titleA severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetineen_US
dc.titleA severe (type II) hepatopulmonary syndrome in a patient with idiopathic portal hypertension and treatment with paroxetine
dc.typeArticleen_US

Dosyalar